Stryker announced that it has completed the acquisition of Amplitude Vascular Systems, Inc. (AVS), which is developing a next-genera ...

Babul will lead U.S. market readiness for VCD’s investigational vein closure technology. Denna Babul, RN, joins VCD Medical ...

In the CARPOOL study, radial-to-peripheral (R2P) access achieved procedural success rates comparable to traditional common ...

Embolization, Inc., will present its novel vascular embolization device, using proprietary shape-memory biocompatible polymers, at the Annual GEST Conference, Booth No. 403, May 14-17 in New York.

We are grateful for this Breakthrough Device Designation from the FDA, recognizing that the patients we serve cannot ...

Midline catheters play a vital role between peripheral IVs and central lines, but coding and billing them accurately requires careful attention to procedural details and payer rules. Correct CPT ...

CEO, Teleflex. Previous title: Senior vice president, president of coronary and renal denervation, Medtronic. Jason Weidman ...

Teleflex (NYSE:TFX) announced today that it appointed Medtronic executive Jason Weidman as its new president and CEO.

The TAVVE study will begin later this year with ten patients, whose 30-day safety results will be submitted to the FDA.

Results from the largest real-world propensity-matched comparison to date show that radial-to-peripheral (R2P) access achieves procedural success rates comparable to traditional common femoral artery ...

Objective Billions of vascular access devices (VADs) are inserted annually for intravenous therapy worldwide. However, their use is not without challenges. Facilitating the process and enhancing ...

Top-down, pixel-art stealth-action – old-school NES-style – is back on the menu with Intravenous 3, the latest in the retro-styled series where you play single-player or in two-player co-op as Steve ...